Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: ECOGStatus: Closed to Accrual. Pts Have Completed InterventionReview Status: Available to Open
